Abstract

Renal involvement is a frequent consequence of plasma cell dyscrasias. The most common entities are light chain amyloidosis, monoclonal immunoglobulin deposition disease and myeloma cast nephropathy. Despite a common origin, each condition has its own unique histologic and pathophysiologic characteristic which requires a renal biopsy to distinguish. Recent studies have shown urinary exosomes containing kidney-derived membrane and cytosolic proteins that can be used to probe the proteomics of the entire urinary system from the glomerulus to the bladder. In this study, we analyzed urine exosomes to determine the differences between exosomes from patients with light chain amyloidosis, multiple myeloma, monoclonal gammopathy of undetermined significance, and non-paraproteinemia related kidney disease controls. In patients with light chain amyloidosis, multiple myeloma and monoclonal gammopathy of undetermined significance, immunoreactive proteins corresponding to monomeric light chains were found in exosomes by western blot. In all of the amyloidosis samples with active disease, high molecular weight immunoreactive species corresponding to a decamer were found which were not found in exosomes from the other diseases or in amyloidosis exosomes from patients in remission. Few or no light chains monomeric bands were found in non-paraproteinemia related kidney disease controls. Our results showed that urinary exosomes may have tremendous potential in furthering our understanding of the pathophysiology and diagnosis of plasma cell dyscrasia related kidney diseases.

Highlights

  • Immunoglobulin light chain (AL) amyloidosis is the consequence of a plasma cell dyscrasia characterized by deposition of amyloid fibrils composed of immunoglobulin light chain [1]

  • Since AL amyloidosis is dependent on the light chains, multiple myeloma is not required for its development,20% of AL amyloidosis cases will have .20% plasma cells in the bone marrow

  • The diagnosis for the AL amyloidosis was confirmed by renal biopsy using standard immunohistochemistry techniques

Read more

Summary

Introduction

Immunoglobulin light chain (AL) amyloidosis is the consequence of a plasma cell dyscrasia characterized by deposition of amyloid fibrils composed of immunoglobulin light chain [1]. A small number of light chains misfold and form protofilaments. The protofilaments assemble to form amyloid fibrils [2]. The processes of amyloid formation and deposition are toxic to organs resulting in progressive organ failure and eventual death if left untreated [3]. Since AL amyloidosis is dependent on the light chains, multiple myeloma is not required for its development ,20% of AL amyloidosis cases will have .20% plasma cells in the bone marrow. Because the source of amyloid formation is the monoclonal light chains, current treatments have focused on reducing the plasma cell population [4]

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.